Royal Bank of Canada
HZNP

Royal Bank of Canada’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Royal Bank of Canada’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,400
Closed -$4.72M – 8197
2021
Q2 		$4.72M Buy
+50,400
New +$4.64M ﹤0.01% 2351

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal Bank of Canada's HZNP Position: Q4 2023 in Review

Royal Bank of Canada sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 27,155 shares — an estimated $3.14M sold.

Royal Bank of Canada first reported a position in HZNP in Q3 2013 and held it in 39 quarters. The position peaked at $27.9M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Royal Bank of Canada reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 27,155 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $3.14M.
  • Royal Bank of Canada first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and held it in 39 quarters.
  • Royal Bank of Canada's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $27.9M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.